The Federal Institute for Drugs and Medical Devices (BfArM) maintains a list of rapid tests that are reimbursed when using the rapid antigen tests of the Federal National Testing Strategy in accordance with the Coronavirus Test Regulation of November 30, 2020: List of Manufacturers. The list will be established using minimum criteria and based on manufacturer information. These minimum criteria will be developed by the PEI in consultation with the RKI and adjusted as they progress.